Mariangela Garofalo received a Master's Degree in Medical Biotechnology in 2011 at the University Federico II of Naples and a Ph.D. in Biochemistry and Cell and Molecular Biology, in co-supervision University of Naples - University of Helsinki in 2015. During her PhD, she moved to Finland where she spent 2 years as visiting student finalizing her PhD thesis in the ImmunoVirotherapy Lab at the Division of Pharmaceutical Biosciences, University of Helsinki (2013-2015). From 2015 to 2017 she carried out her post-doctoral research at the Faculty of Pharmacy (University of Helsinki); after that, she worked as a post-doctoral researcher at the Department of Oncology and Hemato-Oncology at the University of Milan (2017-2019) where she was involved in multidisciplinary research activities in collaboration withIRCCS National Cancer Institute (INT).